What will SPCX's closing share price (USD) be 30 calendar days after the IPO insider lockup expires?

rationale:

The target date for this forecast is January 7, 2027, precisely 30 calendar days after the expiration of the 180-day IPO lock-up on December 8, 2026. SPCX is currently trading in the $145–$146 range, down roughly 15% from its recent October 6 high of $171.92 SpaceX Stock (SPCX) Moved Down by 3.36% on Oct 16 SPCX - Space Exploration Technologies Corp Stock Price .... I am projecting a baseline median of $138.0, applying a modest discount to spot prices to account for the immediate shock of the impending supply overhang and recent headwinds in the broader AI and semiconductor markets. Evaluating this alongside the prior Q3 earnings milestone , the lower median accounts for peak supply pressure immediately following the final December lock-up.

Lock-up Schedule and Supply Risk The primary downward pressure stems from a massive influx of sellable shares arriving before the target date. Following anticipated Q3 results around October 20 SpaceX to Post Third Quarter 2026 Results and Host ..., a 28% lock-up tranche (up to 1.3 billion shares) will unlock two trading days later, followed by another 7% on October 24. Finally, up to 797.6 million shares will be released on December 8. In total, approximately 2.1 billion new shares will become tradable. While the market has partially priced in these known events—and past releases have shown mixed price action, such as a 1.4% rise on the August 6 unlock SpaceX stock climbs as shares available for trading more ... versus drops on subsequent dates SpaceX Stock Slides as Second Lockup Expires SpaceX Stock Has Climbed About 50% Through 6 Insider ...—the sheer volume of supply warrants caution. Notably, no further unlocks are scheduled between December 8 and January 7, giving the market a month to digest the final tranche.

Bullish Catalysts and Upside Potential To the upside, SpaceX's fundamental momentum is exceptionally strong. Management has targeted a $100 billion annualized revenue run rate by December, bolstered by a new hosting deal set to add $1.11 billion monthly starting December 1 https://finance.yahoo.com/markets/stocks/article/spacex-signs-another-ai-computing-deal-with-100-billion-in-arr-on-track-cfo-says-152933886.html. Operational milestones, such as Starship Flight 14 reaching orbit , continue to validate the company's core technological edge. Analysts are highly optimistic, issuing price targets between $228 and $300 SPCX - Space Exploration Technologies Corp Stock Price ... https://finance.yahoo.com/markets/stocks/article/spacex-stock-climbs-again-hits-another-multimonth-closing-high-150109145.html, and speculative wildcards like a potential Tesla merger https://www.benzinga.com/trading-ideas/movers/26/10/62409843/space-stock-watch-spacex-spectrum-deal-rocket-lab-delays-tesla-merger-chatter SpaceX Earnings Due Amid AI Revenue Surge, Tesla ... provide significant support for the right tail, reflected in a p90 of $195.0.

Bearish Risks and Capital Intensity Conversely, the company's massive capital expenditure is a structural drag. Capex is running at roughly $18 billion per quarter, vastly outpacing operating cash flow. Recent reports that SpaceX is seeking $40 billion in new debt to finance Nvidia chips https://finance.yahoo.com/markets/stocks/article/spacex-stock-slips-on-report-of-its-40-billion-in-new-debt-for-nvidia-chips-140223011.html, alongside an $8 billion spectrum purchase , underscore a highly leveraged growth strategy. These capital requirements are colliding with a deteriorating macro backdrop, where the Nasdaq recently shed 4.5% in a week amidst sticky inflation data and growing skepticism over AI financing https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-sp-500-nasdaq-break-coreweave-dell-tesla-spacex-meta/ S&P 500 ends higher as traders shift from AI to healthcare. A weak Q3 report or an intensified macro selloff could push the stock to retest its August lows, placing the p10 at $98.0.

Volatility and Tail Risk Options implied volatility currently sits at roughly 55% to 60%. Over the approximately 55 trading days until January 7, this translates to a lognormal standard deviation of about 0.28. Given the overlapping risks of major share unlocks, Q3 earnings volatility, and systemic market shifts, the resulting distribution features appropriately widened tails. Evaluating the January timeline against longer-term expectations for the company's subsequent late-March earnings release increases uncertainty at both ends because the target date captures the immediate unlock shock well before that later fundamental checkpoint. The central 50% interval therefore runs from $120.0 to $165.0, around the $138.0 median, while the full p10-to-p90 range extends from $98.0 to $195.0. This spread effectively captures the significant variance between an AI-driven revenue surge and a liquidity-driven macro selloff.